These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 10769689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP, Searle PF, Mautner V, James ND.
    Cancer Res; 2000 Jan 15; 60(2):334-41. PubMed ID: 10667585
    [Abstract] [Full Text] [Related]

  • 4. Expression of prostate specific antigen (PSA) is negatively regulated by p53.
    Gurova KV, Roklin OW, Krivokrysenko VI, Chumakov PM, Cohen MB, Feinstein E, Gudkov AV.
    Oncogene; 2002 Jan 03; 21(1):153-7. PubMed ID: 11791186
    [Abstract] [Full Text] [Related]

  • 5. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y, McCadden J, Ferrer F, Kruszewski M, Carducci M, Simons J, Rodriguez R.
    Cancer Res; 2002 May 01; 62(9):2576-82. PubMed ID: 11980652
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ, Slawin KM, Spencer DM.
    Cancer Res; 2001 Sep 15; 61(18):6795-804. PubMed ID: 11559553
    [Abstract] [Full Text] [Related]

  • 10. Prostate-specific targeting using PSA promoter-based lentiviral vectors.
    Yu D, Chen D, Chiu C, Razmazma B, Chow YH, Pang S.
    Cancer Gene Ther; 2001 Sep 15; 8(9):628-35. PubMed ID: 11593331
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing the transcription activity of enhancers in different directions].
    Zeng H, Liao YC, Wang F, Wu Q, Yang YR.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov 15; 36(6):782-5. PubMed ID: 16334552
    [Abstract] [Full Text] [Related]

  • 13. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
    Kraaij R, van der Weel L, de Ridder CM, van der Korput HA, Zweistra JL, van Rijswijk AL, Bangma CH, Trapman J.
    Prostate; 2007 Jun 01; 67(8):829-39. PubMed ID: 17394196
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
    Chapel-Fernandes S, Jordier F, Lauro F, Maitland N, Chiaroni J, de Micco P, Mannoni P, Bagnis C.
    Cancer Gene Ther; 2006 Oct 01; 13(10):919-29. PubMed ID: 16741521
    [Abstract] [Full Text] [Related]

  • 16. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY, Onita T, Ji PG, Sakai H, Chan FL, Koropatnick J, Chin JL, Moussa M, Xuan JW.
    Gene Ther; 2002 Dec 01; 9(23):1589-99. PubMed ID: 12424611
    [Abstract] [Full Text] [Related]

  • 17. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
    Majumdar S, Diamandis EP.
    Br J Cancer; 1999 Mar 01; 79(9-10):1594-602. PubMed ID: 10188912
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.
    Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW.
    J Urol; 1998 Jul 01; 160(1):220-9. PubMed ID: 9628654
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.